KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Common Equity (2016 - 2025)

Historic Common Equity for Medpace Holdings (MEDP) over the last 11 years, with Q3 2025 value amounting to $293.6 million.

  • Medpace Holdings' Common Equity fell 6668.62% to $293.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $293.6 million, marking a year-over-year decrease of 6668.62%. This contributed to the annual value of $825.5 million for FY2024, which is 4769.57% up from last year.
  • As of Q3 2025, Medpace Holdings' Common Equity stood at $293.6 million, which was down 6668.62% from $172.4 million recorded in Q2 2025.
  • In the past 5 years, Medpace Holdings' Common Equity ranged from a high of $952.9 million in Q4 2021 and a low of $172.4 million during Q2 2025
  • Over the past 5 years, Medpace Holdings' median Common Equity value was $593.6 million (recorded in 2025), while the average stood at $587.2 million.
  • Its Common Equity has fluctuated over the past 5 years, first skyrocketed by 9526.39% in 2024, then tumbled by 7742.91% in 2025.
  • Quarter analysis of 5 years shows Medpace Holdings' Common Equity stood at $952.9 million in 2021, then plummeted by 59.45% to $386.4 million in 2022, then soared by 44.66% to $558.9 million in 2023, then surged by 47.7% to $825.5 million in 2024, then tumbled by 64.43% to $293.6 million in 2025.
  • Its Common Equity was $293.6 million in Q3 2025, compared to $172.4 million in Q2 2025 and $593.6 million in Q1 2025.